• Home
  • Terms of Use
  • Privacy Policy
  • Disclosure
Monday, May 16, 2022
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Videos
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Videos
No Result
View All Result
Omicron b11529 Variant
No Result
View All Result
Home Covid-19

About 15 Million Additional Deaths Attributed To COVID-19 Between January 2020 And December 2021 – News-Medical.Net

by NewsReporter
May 10, 2022
in Covid-19
Reading Time: 4 mins read
Share on FacebookShare on Twitter

The World Health Organization (WHO) has released new figures showing that the coronavirus disease 2019 (COVID-19) pandemic caused almost 15 million deaths directly or indirectly. These deaths comprise the excess mortality over the two years 2020 and 2021, attributable to infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Based on the mortality statistics from pre-pandemic years, excess mortality is calculated as the number of deaths that have occurred compared to the expected number.

Report: Global excess deaths associated with COVID-19, January 2020 – December 2021. Image Credit: VK Studio / Shutterstock

Why Excess Mortality?

Many countries report the number of cases and deaths due to COVID-19 daily. Consequently, they’re not a good gauge of the pandemic’s true impact.

The excess deaths could be due to those occurring as a result of critical COVID-19 or those which occurred because of indirect effects. For instance, people with other health conditions might have been unable to access needed healthcare because of the overwhelming impact of the virus on healthcare systems or the loss of trained professionals to quarantine, disease, death, or burnout.

On the other hand, some groups who might reasonably have been expected to show high mortality rates might experience a dip, like motorcycle riders, because of the reduced travel after shelter-in-place orders. Occupational injuries leading to death could also be markedly lower because of the closure of many businesses.

As such, excess mortality is both a more complete and a more comparable measure. There were actually fewer deaths in some countries than expected as a result of almost nonexistent mortality from seasonal illnesses like influenza and fewer fatal traffic accidents.

It is also important to note that the excess mortality is a statistical estimate based on the input data, the model adopted, and assumptions as to the expected deaths from various causes. The method used by the WHO takes specific factors for each country, such as income, reported mortality rates due to COVID-19, and test positivity rates, into consideration rather than applying uniform assumptions to all countries alike.

The areas with the highest excess mortality include South-East Asia, Europe, and the American continents, which account for almost 85% of these deaths. Nearly 70% of total deaths come from ten countries alone, while over 80% come from countries with a middle-income level.

In contrast, high-income countries account for 15%, while low-income countries, surprisingly, contribute 4%. Of the middle-income countries, the majority (53%) come from lower-middle-income countries, and 28% from higher-middle-income countries.

When stratified by sex, the results confirm that the pandemic had a heavier impact on men, with over 57% of deaths in male patients. Older people were also disproportionately affected.

For a better understanding of how hard a virus hit a region, look at the excess deaths per 100,000 population rather than the absolute numbers, since the latter is influenced by population size.

Where do these figures come from? The report cites a collaborative project supported by the statistics generated by the Technical Advisory Group for COVID-19 Mortality Assessment, along with the reports from each country. The former is an initiative of both the WHO and the United Nations Department of Economic and Social Affairs (UN DESA), comprising many top experts who have come up with a novel way of finding mortality rate estimates that can be compared with each other.

This can be achieved even in the absence of data, or when only incomplete data is available. As such, it is a great boon for countries that lack surveillance systems, or whose systems don’t work as expected. The methodology has been made publicly available so that countries can update their mortality estimates using it.

The Importance of Excess Mortality

A measure of excess mortality is necessary to understand how the pandemic is evolving and to develop policies that prevent further deaths. The collection of data is essential to understanding the true extent of excess mortality, and this is often lacking or woefully inadequate in many countries. This means that “the true extent of excess mortality often remains hidden,” according to the WHO’s Assistant Director-General for Data, Analytics and Delivery, Samira Asma.

Describing data as “the foundation of our work,” Assistant Director-General for Emergency Response, Dr. Ibrahima Socé Fall, goes on to say, “we must collectively intensify our support to countries, so that every country has the capability to track outbreaks in real-time, ensure delivery of essential health services, and safeguard population health.”

Further underlining this area of need, UN DESA Director of the Statistics Division, Mr. Stefan Schweinfest, says, “Data deficiencies make it difficult to assess the true scope of a crisis. The pandemic has been a stark reminder of the need for better coordination of data systems and for increased international support for building better systems.”

WHO Initiatives

In keeping with these felt needs, the WHO provides an array of tools such as the SCORE for Health Data Technical Package (Survey, Count, Optimize, Review, Enable), the World Health Survey Plus (WHS+), the Routine Health Information Systems (RHIS) strategy, the WHO Toolkit for Routine Health Information Systems Data, and the WHO Harmonized Health Facility Assessment (HHFA). With these data solutions, it is hoped that public health decisions will be more productive and responsive, aiding in building better quality into foundational health services and preparing them to deal effectively with emergencies.

Source:

Journal reference:

Related Posts

two-on-peninsula-die-from-covid-19-–-peninsula-daily-news

Two On Peninsula Die From COVID-19 – Peninsula Daily News

by NewsReporter
May 16, 2022
0

Two North Olympic Peninsula residents have died from COVID-19, breaking a weeks-long streak of no deaths from the virus in the region while the national toll from the virus neared 1 million. Three people were hospitalized with the virus on the Peninsula as of Friday, including a child younger than...

covid-19-vaccines-in-patients-with-decompensated-cirrhosis:-a-retrospective-cohort-on-safety-data-and-risk-factors-associated-with-unvaccinated-status-–-infectious-diseases-of-poverty-–-infectious-diseases-of-poverty-–-biomed-central

COVID-19 Vaccines In Patients With Decompensated Cirrhosis: A Retrospective Cohort On Safety Data And Risk Factors Associated With Unvaccinated Status – Infectious Diseases Of Poverty – Infectious Diseases Of Poverty – BioMed Central

by NewsReporter
May 16, 2022
0

Research Article Open Access Published: 16 May 2022 Zhujun Cao1 na1, Chenxi Zhang1,2 na1, Shuang Zhao1, Zike Sheng1, Xiaogang Xiang1, Ruokun Li3, Zhuping Qian1,4, Yinling Wang1,5, Bin Chen1,6, Ziqiang Li1, Yuhan Liu1, Baoyan An1, Huijuan Zhou1, Wei Cai1, Hui Wang1, Honglian Gui1, Haiguang Xin1 & Qing Xie  ORCID: orcid.org/0000-0002-2582-88031  Infectious Diseases of...

synairgen-shares-rise-on-positive-analysis-of-phase-3-covid-19-treatment-trial-–-marketwatch

Synairgen Shares Rise On Positive Analysis Of Phase 3 Covid-19 Treatment Trial – MarketWatch

by NewsReporter
May 16, 2022
0

By Michael Susin Shares in Synairgen PLC rose on Monday after the company said that the posterior analysis of a Phase 3 study of its Covid-19 inhalatory antiviral treatment suggests it may have an important clinical effect on high-risk patients. Shares at 0752 GMT were up 7.3 pence, or 27%,...

skorea-offers-working-level-talks-to-n.korea-on-covid-19-–-the-jerusalem-post

S.Korea Offers Working Level Talks To N.Korea On COVID-19 – The Jerusalem Post

by NewsReporter
May 16, 2022
0

South Korea's unification ministry has offered to hold working-level talks with North Korea on offering support for its neighbor, which is battling its first confirmed outbreak of COVID-19, the ministry said on Monday.The ministry, charged with maintaining relations between the two nations, said it had expressed willingness to provide medicines,...

valneva-receives-notice-of-european-commission’s-intent-to-terminate-covid-19-vaccine-purchase-agreement-–-biospace

Valneva Receives Notice Of European Commission’s Intent To Terminate COVID-19 Vaccine Purchase Agreement – BioSpace

by NewsReporter
May 16, 2022
0

Saint-Herblain (France), May16, 2022 – ValnevaSE, a specialty vaccine company, today announced that it has received a notice from the European Commission (“EC”) of intent to terminate the advance purchase agreement (“APA”) for Valneva’s inactivated whole-virus COVID-19 vaccine candidate VLA2001. The APA provides the EC with a right to terminate...

covid-19’s-3-lessons-learned-in-new-mexico-–-albuquerque-journal

COVID-19’s 3 Lessons Learned In New Mexico – Albuquerque Journal

by NewsReporter
May 16, 2022
0

Two years ago, the COVID-19 pandemic upended life as we all knew it. People all over the world were suddenly struck by isolation, frustration and fear. In 2020, we all hoped that stay-at-home orders, the widespread utilization of masks, and the desperate call for vaccine development would be the solutions...

Omicron b11529 Variant

© 2021

Navigate Site

  • Home
  • Terms of Use
  • Privacy Policy
  • Disclosure

Follow Us

No Result
View All Result
  • Home

© 2021